Cognition Therapeutics Q3 EPS $(0.04) Beats $(0.07) Estimate
Cognition Therapeutics (NASDAQ:CGTX) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.07) by 42.86 percent. This is a 33.33 percent increase over losses of $(0.06) per
Share
Why It Matters
Cognition Therapeutics lost less money than experts thought it would. When a company that is losing money loses less than expected, it shows good progress on the path to health.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.